101 related articles for article (PubMed ID: 1619944)
1. Schedule dependent inhibition of thymidylate synthase and tumor growth by 5-fluorouracil in Yoshida sarcoma bearing rats.
Tsujinaka T; Kido Y; Shiozaki H; Mori T
J Surg Oncol; 1992 Jul; 50(3):190-4. PubMed ID: 1619944
[TBL] [Abstract][Full Text] [Related]
2. Schedule-dependent inhibition of thymidylate synthase by 5-fluorouracil in gastric cancer.
Tsujinaka T; Kido Y; Shiozaki H; Iijima S; Homma T; Sakaue M; Mori T
Cancer; 1992 Dec; 70(12):2761-5. PubMed ID: 1451052
[TBL] [Abstract][Full Text] [Related]
3. Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo.
Shirasaka T; Shimamoto Y; Ohshimo H; Saito H; Fukushima M
Cancer Chemother Pharmacol; 1993; 32(3):167-72. PubMed ID: 8500219
[TBL] [Abstract][Full Text] [Related]
4. [The mechanism of potentiation of the antitumor effect of 5-fluorouracil by methionine-free intravenous amino acid solution (AO-90) in rats].
Hibino Y; Kawarabayashi Y; Kohri H; Ueda N; Tsukagoshi S
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2021-8. PubMed ID: 8085853
[TBL] [Abstract][Full Text] [Related]
5. [Innate resistance to thymidylate synthase inhibition after 5-fluorouracil treatment--a rationale of combined use of cisplatin and its optimal administration dose].
Omura K; Hashimoto T; Kawakami K; Kanehira E; Watanabe T; Hirano K; Watanabe S; Watanabe Y; Shirasaka T
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2007-11. PubMed ID: 8085851
[TBL] [Abstract][Full Text] [Related]
6. [The significance of measuring inhibition of thymidylate synthase activity as a parameter for antitumor activity of 5-fluorouracil derivatives].
Takeda S; Uchida J; Yamada Y; Unemi N; Fujii S
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2125-30. PubMed ID: 3395138
[TBL] [Abstract][Full Text] [Related]
7. In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas.
Spears CP; Shahinian AH; Moran RG; Heidelberger C; Corbett TH
Cancer Res; 1982 Feb; 42(2):450-6. PubMed ID: 6173112
[TBL] [Abstract][Full Text] [Related]
8. Persistent induction of apoptosis and suppression of mitosis as the basis for curative therapy with S-1, an oral 5-fluorouracil prodrug in a colorectal tumor model.
Cao S; Lu K; Tóth K; Slocum HK; Shirasaka T; Rustum YM
Clin Cancer Res; 1999 Feb; 5(2):267-74. PubMed ID: 10037174
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of fluoropyrimidines depends on the duration of thymidylate synthase inhibition in the murine colon 26-B carcinoma tumor model.
van Laar JA; van der Wilt CL; Rustum YM; Noordhuis P; Smid K; Pinedo HM; Peters GJ
Clin Cancer Res; 1996 Aug; 2(8):1327-33. PubMed ID: 9816304
[TBL] [Abstract][Full Text] [Related]
10. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
[TBL] [Abstract][Full Text] [Related]
11. Effects of the plasma concentration of 5-fluorouracil and the duration of continuous venous infusion of 5-fluorouracil with an inhibitor of 5-fluorouracil degradation on Yoshida sarcomas in rats.
Fujii S; Shimamoto Y; Ohshimo H; Imaoka T; Motoyama M; Fukushima M; Shirasaka T
Jpn J Cancer Res; 1989 Feb; 80(2):167-72. PubMed ID: 2498251
[TBL] [Abstract][Full Text] [Related]
12. Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331.
Ford HE; Mitchell F; Cunningham D; Farrugia DC; Hill ME; Rees C; Calvert AH; Judson IR; Jackman AL
Clin Cancer Res; 2002 Jan; 8(1):103-9. PubMed ID: 11801545
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil.
Spears CP; Gustavsson BG; Mitchell MS; Spicer D; Berne M; Bernstein L; Danenberg PV
Cancer Res; 1984 Sep; 44(9):4144-50. PubMed ID: 6744325
[TBL] [Abstract][Full Text] [Related]
14. [Enhancement of 5-fluorouracil (5-FU) antitumor effect of amino acid solution (methionine deprived amino acid solution: AO-90) in 5-FU-resistant Yoshida sarcoma].
Hibino Y; Kawarabayashi Y; Kuwahata T; Ueda N; Shinguu H
Gan To Kagaku Ryoho; 1991 May; 18(6):1055-7. PubMed ID: 2029192
[No Abstract] [Full Text] [Related]
15. Effect of consecutive lower-dose cisplatin in enhancement of 5-fluorouracil cytotoxicity in experimental tumor cells in vivo.
Araki H; Fukushima M; Kamiyama Y; Shirasaka T
Cancer Lett; 2000 Nov; 160(2):185-91. PubMed ID: 11053648
[TBL] [Abstract][Full Text] [Related]
16. High-dose 5-Fluorouracil with uridine-diphosphoglucose rescue increases thymidylate synthase inhibition but not 5-Fluorouracil incorporation into RNA in murine tumors.
Codacci-Pisanelli G; Van der Wilt CL; Smid K; Noordhuis P; Voorn D; Pinedo HM; Peters GJ
Oncology; 2002; 62(4):363-70. PubMed ID: 12138245
[TBL] [Abstract][Full Text] [Related]
17. Changes in thymidylate synthase and its inhibition rate and changes in dihydropyrimidine dehydrogenase after the administration of 5-fluorouracil with cisplatin to nude mice with gastric cancer xenograft SC-1-NU.
Sakurai Y; Uraguchi T; Imazu H; Hasegawa S; Matsubara T; Ochiai M; Funabiki T
Gastric Cancer; 2004; 7(2):110-6. PubMed ID: 15224198
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of innate resistance to thymidylate synthase inhibition after 5-fluorouracil.
Spears CP; Gustavsson BG; Berne M; Frösing R; Bernstein L; Hayes AA
Cancer Res; 1988 Oct; 48(20):5894-900. PubMed ID: 3167844
[TBL] [Abstract][Full Text] [Related]
19. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil.
Peters GJ; van der Wilt CL; van Groeningen CJ; Smid K; Meijer S; Pinedo HM
J Clin Oncol; 1994 Oct; 12(10):2035-42. PubMed ID: 7931471
[TBL] [Abstract][Full Text] [Related]
20. Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil.
Yeh KH; Yeh SH; Hsu CH; Wang TM; Ma IF; Cheng AL
Br J Cancer; 2000 Dec; 83(11):1510-5. PubMed ID: 11076661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]